Zymeworks (ZYME) Cash & Current Investments (2021 - 2026)
Zymeworks' Cash & Current Investments came in at $270.7 million for Q2 2026, down 3.8% from $281.38 million a year earlier and down 25.8% from the prior quarter.
Powered by 
Analysis
Zymeworks (ZYME) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Zymeworks' Cash & Current Investments was $228.8 million, up 1.3% from FY2024.
- Cash & Current Investments carries a four-year compound annual growth rate of -2.4% (FY2021 to FY2025).
- Going back by year, Cash & Current Investments was $225.78 million in FY2024 (-39.7%), $374.33 million in FY2023 (-24.0%), $492.23 million in FY2022 (+94.9%) and $252.61 million in FY2021.
- The five-year range for quarterly Cash & Current Investments is $166.24 million (Q3 2022) to $492.23 million (Q4 2022).
- Year-over-year, Cash & Current Investments increased in three of the last eight quarters, with an average decline of 7.1%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2022 (growth of 94.9%), and the weakest in Q4 2024 (a decline of 39.7%).
- Business Quant data shows ZYME's Cash & Current Investments at $364.73 million (Q1 2026), $228.8 million (Q4 2025) and $251.93 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Zymeworks | 1.80 Bn | 679.86 Mn | - | 270.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 270.70 Mn |
| Mar 31, 2026 | 364.73 Mn |
| Dec 31, 2025 | 228.80 Mn |
| Sep 30, 2025 | 251.93 Mn |
| Jun 30, 2025 | 281.38 Mn |
| Mar 31, 2025 | 265.29 Mn |
| Dec 31, 2024 | 225.78 Mn |
| Sep 30, 2024 | 297.20 Mn |
| Jun 30, 2024 | 330.15 Mn |
| Mar 31, 2024 | 345.05 Mn |
| Dec 31, 2023 | 374.33 Mn |
| Sep 30, 2023 | 295.41 Mn |
| Jun 30, 2023 | 340.09 Mn |
| Mar 31, 2023 | 340.79 Mn |
| Dec 31, 2022 | 492.23 Mn |
| Sep 30, 2022 | 166.24 Mn |
| Dec 31, 2021 | 252.61 Mn |
API Access
Zymeworks Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ZYME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ZYME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ZYME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();